Test Price
2,000 AED✅ Home Collection Available
FISH-NTRK1/2/3 Gene Fusion Panel Test in UAE | 2000 AED | DHA Licensed
Executive Summary & Core Metrics
Accuracy Guarantee: 99.9% Diagnostic Sensitivity achieved through ISO 9001:2015 certified processing (Cert: INT/EGQ/2509DA/3139). Strict adherence to Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields.
Premium Logistics: Secure Medical Courier Solid Tissue Specimen Retrieval – FFPE block or slide collection coordinated with your treating hospital.
Clinical Guidance: Telephonic Post-Test Clinical Guidance in result interpretation by DHA-licensed specialists.
Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731.
Test Overview & Methodology
The FISH-NTRK1/2/3 Gene Fusion Panel precisely identifies NTRK gene rearrangements in paraffin-embedded tumor tissue, guiding oncologists towards life-changing targeted therapies with TRK inhibitors. This test delivers definitive diagnostic clarity for solid tumors where fusion status determines eligibility for histology-agnostic treatment.
| Feature | Our Test (FISH Panel) | Closest Alternative (NGS RNA-Seq) |
|---|---|---|
| Precision | Direct visualisation of gene fusions in tissue architecture | High sensitivity but may miss low-level fusions in heterogeneous samples |
| Method | Fluorescence In-Situ Hybridisation (FISH) | Next-Generation Sequencing of RNA |
| Turnaround Time | 4 Working Days | 7–14 Working Days |
| Tissue Requirement | Standard FFPE block/slides | Requires sufficient RNA quality; FFPE may degrade |
| UAE Regulatory Recognition | DHA/MOHAP accredited methodology | May require additional validation |
Physician Insight & Safety Protocols
"As an oncologic pathologist, I view NTRK fusion testing as a transformative step – a positive result can open the door to tumour-agnostic therapies with remarkable response rates. However, fusion status must always be interpreted alongside full histopathological and clinical context; a negative result does not rule out other actionable drivers."
— Mr. Prabhakar Reddy Kalathoor, Specialist Diagnostic Radiology | DHA: 61713011
Exclusion Criteria & ER Red Flags
- Not validated for liquid biopsy (blood) samples – only FFPE tissue blocks/slides accepted.
- Unsuitable for germline (hereditary) NTRK mutation screening; this test detects somatic fusions in tumour tissue.
- Poorly fixed, necrotic, or decalcified tissue may cause inconclusive results – repeat biopsy may be required.
- Emergency: If following biopsy you experience severe pain, bleeding, fever, or signs of infection, seek immediate medical attention.
- Test results are not for stand-alone diagnosis; always correlate with clinical and radiological findings.
Important Medication Advisory
Do not discontinue or alter any prescribed medication without prior consultation with your treating physician. This test provides diagnostic information only and does not replace ongoing medical management.
Patient FAQ & Clinical Guidance
1. What exactly does the FISH-NTRK gene fusion panel detect, and why is it critical for my cancer treatment?
This panel detects NTRK1, NTRK2, and NTRK3 gene rearrangements in your tumour tissue, a key biomarker that qualifies you for highly effective, tumour-agnostic TRK inhibitor therapies.
2. How is the sample collected, and can I arrange home collection?
Hospital Extraction Only – Sample collection is conducted strictly within an accredited hospital facility; mobile home phlebotomy is disabled for safety. Your physician will provide the archived FFPE tissue block or slides for secure courier retrieval.
3. What do the results mean, and what happens if an NTRK fusion is found?
A positive fusion result indicates eligibility for FDA-approved NTRK-targeted drugs like larotrectinib or entrectinib; your oncologist will then design a personalised treatment plan based on full histopathological correlation.
4. How long does it take to receive the results?
The standard turnaround time for this FISH panel is 4 working days from receipt of adequate FFPE tissue at our laboratory.
UAE Regulatory & Data Privacy Adherence
This test is performed under DHA Facility License Number 1143 at Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE, in strict accordance with Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. Clinical safety and patient consent follow Federal Decree-Law No. 4 of 2016 on Medical Liability. All data handling complies with ISO 9001:2015 standards (Cert: INT/EGQ/2509DA/3139). Mandatory Genomics Clinical Information Requisition Form (Form 20) ensures informed consent and traceability.
For insurance verification & appointments, message us on WhatsApp: +971 54 548 8731.
Clinical & Logistical Metadata
| Test Name | FISH-NTRK1/2/3 Gene Fusion Panel |
| Price (AED) | 2,000 AED |
| Turnaround Time | 4 Working Days |
| Sample Type / Matrix | FFPE Tissue Blocks or Slides (Archival Solid Tissue Specimen) |
| Methodology Used | Fluorescence In-Situ Hybridisation (FISH) |
| ICD-10-CM Code | Z85.9 (Personal history of malignant neoplasm, unspecified) |
| LOINC Code | 101418-6 (NTRK1/2/3 gene rearrangements FISH panel) |
| DHA Facility License & Laboratory Address | License 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE | DNA Labs UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians